Status:

COMPLETED

Acceptance and Commitment Group Therapy (ACT) for Patients With Health Anxiety

Lead Sponsor:

University of Aarhus

Conditions:

Hypochondriasis

Somatization Disorder

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the effect of Acceptance and Commitment Therapy (ACT) in groups on functional level, emotional problems, and use of health care in patients with severe health...

Detailed Description

Health anxiety disorder or Hypochondriasis is a prevalent somatoform disorder, but a rarely used diagnosis in clinical practice despite studies having reported prevalence between 0.8-9.5% in primary c...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Whiteley-7 score on 21,4 or more (scale 0-100 score points).
  • Severe health anxiety (diagnosed by SCAN interview).
  • Age 20-60 years
  • Patients of Scandinavian origin who understand, read, write and speak Danish.
  • No lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)
  • In case of a co morbid functional or other psychiatric disorder health anxiety must be the dominating problem.
  • Exclusion criteria:
  • Another severe psychiatric disorder or if the patient is suicidal.
  • Abuse of narcotics or alcohol and (non-prescribed) medicine.
  • Pregnancy.
  • No informed consent.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2013

    Estimated Enrollment :

    126 Patients enrolled

    Trial Details

    Trial ID

    NCT01158430

    Start Date

    March 1 2010

    End Date

    April 1 2013

    Last Update

    April 15 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Research Clinic for Functional Disorders, Aarhus University Hospital

    Aarhus C, Denmark, 8000